Claudin-2 was also reported to be increased in tissues taken from CRC and IBD-associated CRC patients and to promote and sustain cell proliferation and tumor growth in cultured cells and experimental models [133]. This evidence concerns the gene CLDN2 and irritable bowel syndrome.